Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker MPLT
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Hanson Kristopher Officer | MPLT MapLight Therapeutics, Inc. | 9,020 | $70.4K | — | Oct 15, 2026 | Form 4 ↗ 1 day later · 9,020 shares | Form 144 ↗ |
| Oct 15, 2026 | Jonathan Gillis Officer | MPLT MapLight Therapeutics, Inc. | 10,167 | $79.4K | — | Oct 15, 2026 | Form 4 ↗ 1 day later · 10,167 shares | Form 144 ↗ |
| Oct 15, 2026 | Foff Erin Pennock Officer | MPLT MapLight Therapeutics, Inc. | 15,355 | $119.9K | — | Oct 15, 2026 | Form 4 ↗ 1 day later · 15,355 shares | Form 144 ↗ |
| Oct 15, 2026 | Christopher A. Kroeger Officer | MPLT MapLight Therapeutics, Inc. | 73,691 | $575.5K | — | Oct 15, 2026 | Form 4 ↗ 1 day later · 73,691 shares | Form 144 ↗ |
| Oct 15, 2026 | Lillie James Woodruff Officer | MPLT MapLight Therapeutics, Inc. | 11,513 | $89.9K | — | Oct 15, 2026 | Form 4 ↗ 1 day later · 11,513 shares | Form 144 ↗ |
| Oct 15, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 14,809 | $115.7K | 10b5-1 | Oct 15, 2026 | — | Form 144 ↗ |
| Oct 15, 2026 | Anatol Kreitzer Officer | MPLT MapLight Therapeutics, Inc. | 12,500 | $97.6K | — | Oct 15, 2026 | Form 4 ↗ 1 day later · 12,248 shares | Form 144 ↗ |
| Sep 16, 2026 | Hanson Kristopher Officer | MPLT MapLight Therapeutics, Inc. | 16,509 | $199.4K | 10b5-1 | Sep 16, 2026 | Form 4 ↗ 2 days later · 16,509 shares | Form 144 ↗ |
| Aug 3, 2026 | Lillie James Woodruff Officer | MPLT MapLight Therapeutics, Inc. | 22,082 | $287.5K | 10b5-1 | Aug 3, 2026 | Form 4 ↗ 1 day later · 22,082 shares | Form 144 ↗ |
| Jul 30, 2026 | Novo Holdings A/S Former Affiliate | MPLT MapLight Therapeutics, Inc. | 1.60M | $24.0M | — | Jul 30, 2026 | — | Form 144 ↗ |
| Jul 17, 2026 | Anatol Kreitzer Officer | MPLT MapLight Therapeutics, Inc. | 17,173 | $639.2K | 10b5-1 | Jul 17, 2026 | Form 4 ↗ 3 days later · 36,284 shares | Form 144 ↗ |
| Jul 17, 2026 | Jonathan Gillis Officer | MPLT MapLight Therapeutics, Inc. | 18,469 | $687.4K | 10b5-1 | Jul 17, 2026 | Form 4 ↗ 3 days later · 36,979 shares | Form 144 ↗ |
| Jul 15, 2026 | Foff Erin Pennock Officer | MPLT MapLight Therapeutics, Inc. | 48,158 | $1.8M | 10b5-1 | Jul 15, 2026 | Form 4 ↗ 2 days later · 47,158 shares | Form 144 ↗ |
| Jul 15, 2026 | Christopher A. Kroeger Officer | MPLT MapLight Therapeutics, Inc. | 152,230 | $5.8M | — | Jul 15, 2026 | Form 4 ↗ 2 days later · 147,639 shares | Form 144 ↗ |
| Jul 15, 2026 | Hanson Kristopher Officer | MPLT MapLight Therapeutics, Inc. | 16,508 | $625.8K | — | Jul 15, 2026 | Form 4 ↗ 2 days later · 16,508 shares | Form 144 ↗ |
| Jul 15, 2026 | Lillie James Woodruff Officer | MPLT MapLight Therapeutics, Inc. | 18,835 | $714.0K | — | Jul 15, 2026 | Form 4 ↗ 2 days later · 18,267 shares | Form 144 ↗ |
| Jul 15, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 17,537 | $664.8K | 10b5-1 | Jul 15, 2026 | — | Form 144 ↗ |
| Jul 15, 2026 amended | Anatol Kreitzer Officer | MPLT MapLight Therapeutics, Inc. | 36,284 | $1.4M | — | Jul 15, 2026 | Form 4 ↗ 5 days later · 36,284 shares | Form 144/A ↗ |
| Jul 15, 2026 | Jonathan Gillis Officer | MPLT MapLight Therapeutics, Inc. | 36,979 | $1.4M | — | Jul 15, 2026 | Form 4 ↗ 5 days later · 36,979 shares | Form 144 ↗ |
| Jul 15, 2026 | Anatol Kreitzer Officer | MPLT MapLight Therapeutics, Inc. | 33,605 | $1.3M | — | Jul 15, 2026 | Form 4 ↗ 5 days later · 36,284 shares | Form 144 ↗ |
| May 4, 2026 | Christopher A. Kroeger Officer | MPLT MapLight Therapeutics, Inc. | 236,470 | $7.3M | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 49,744 shares | Form 144 ↗ |
| May 4, 2026 | Setia Vishwas Officer | MPLT MapLight Therapeutics, Inc. | 36,371 | $1.1M | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 36,371 shares | Form 144 ↗ |
| May 4, 2026 | Foff Erin Pennock Officer | MPLT MapLight Therapeutics, Inc. | 54,718 | $1.7M | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 50,280 shares | Form 144 ↗ |
| May 4, 2026 | Lillie James Woodruff Officer | MPLT MapLight Therapeutics, Inc. | 52,428 | $1.6M | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 51,707 shares | Form 144 ↗ |
| May 4, 2026 | Hanson Kristopher Officer | MPLT MapLight Therapeutics, Inc. | 27,834 | $854.5K | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 13,917 shares | Form 144 ↗ |
| Apr 27, 2026 | Anatol Kreitzer Officer | MPLT MapLight Therapeutics, Inc. | 45,422 | $1.4M | 10b5-1 | Apr 27, 2026 | Form 4 ↗ 2 days later · 45,422 shares | Form 144 ↗ |
| Apr 27, 2026 | Jonathan Gillis Officer | MPLT MapLight Therapeutics, Inc. | 69,835 | $2.1M | 10b5-1 | Apr 27, 2026 | Form 4 ↗ 2 days later · 69,835 shares | Form 144 ↗ |
| Apr 15, 2026 amended | Foff Erin Pennock Officer | MPLT MapLight Therapeutics, Inc. | 3,472 | $93.8K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 3,213 shares | Form 144/A ↗ |
| Apr 15, 2026 amended | Lillie James Woodruff Officer | MPLT MapLight Therapeutics, Inc. | 4,896 | $132.3K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 4,513 shares | Form 144/A ↗ |
| Apr 15, 2026 amended | Setia Vishwas Officer | MPLT MapLight Therapeutics, Inc. | 2,990 | $80.8K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 2,922 shares | Form 144/A ↗ |
| Apr 15, 2026 amended | Hanson Kristopher Officer | MPLT MapLight Therapeutics, Inc. | 1,827 | $49.4K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 1,827 shares | Form 144/A ↗ |
| Apr 15, 2026 | Christopher A. Kroeger Officer | MPLT MapLight Therapeutics, Inc. | 20,822 | $562.6K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 19,187 shares | Form 144 ↗ |
| Apr 15, 2026 | Setia Vishwas Officer | MPLT MapLight Therapeutics, Inc. | 2,990 | $80.8K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 2,922 shares | Form 144 ↗ |
| Apr 15, 2026 | Lillie James Woodruff Officer | MPLT MapLight Therapeutics, Inc. | 4,896 | $132.3K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 4,513 shares | Form 144 ↗ |
| Apr 15, 2026 | Hanson Kristopher Officer | MPLT MapLight Therapeutics, Inc. | 1,827 | $49.4K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 1,827 shares | Form 144 ↗ |
| Apr 15, 2026 | Foff Erin Pennock Officer | MPLT MapLight Therapeutics, Inc. | 3,472 | $93.8K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 3,213 shares | Form 144 ↗ |
| Apr 15, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 8,593 | $232.2K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ 2 days later · 8,593 shares | Form 144 ↗ |
| Apr 15, 2026 | Anatol Kreitzer Officer | MPLT MapLight Therapeutics, Inc. | 5,000 | $135.1K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 3,316 shares | Form 144 ↗ |
| Apr 15, 2026 | Jonathan Gillis Officer | MPLT MapLight Therapeutics, Inc. | 4,000 | $108.1K | — | Apr 15, 2026 | Form 4 ↗ 2 days later · 3,590 shares | Form 144 ↗ |
| Feb 24, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 736 | $13.4K | — | Feb 24, 2026 | Form 4 ↗ same day · 12,000 shares | Form 144 ↗ |
| Feb 23, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 11,264 | $207.5K | — | Feb 23, 2026 | Form 4 ↗ 1 day later · 14,195 shares | Form 144 ↗ |
| Feb 20, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 2,195 | $39.6K | — | Feb 20, 2026 | Form 4 ↗ 4 days later · 14,195 shares | Form 144 ↗ |
| Feb 13, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 12,116 | $220.7K | — | Feb 13, 2026 | Form 4 ↗ 5 days later · 12,116 shares | Form 144 ↗ |
| Feb 11, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 241 | $4,338 | — | Feb 11, 2026 | Form 4 ↗ 1 day later · 6,863 shares | Form 144 ↗ |
| Feb 10, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 6,622 | $120.0K | — | Feb 10, 2026 | Form 4 ↗ 2 days later · 6,863 shares | Form 144 ↗ |
| Feb 3, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 1 | $18 | — | Feb 3, 2026 | Form 4 ↗ 1 day later · 7,040 shares | Form 144 ↗ |
| Feb 2, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 7,039 | $126.8K | — | Feb 2, 2026 | Form 4 ↗ 2 days later · 7,040 shares | Form 144 ↗ |
| Jan 30, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 6,612 | $119.7K | — | Jan 30, 2026 | Form 4 ↗ same day · 34,398 shares | Form 144 ↗ |
| Jan 29, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 21,262 | $394.5K | — | Jan 29, 2026 | Form 4 ↗ 1 day later · 34,398 shares | Form 144 ↗ |
| Jan 28, 2026 | Robert Malenka Director | MPLT MapLight Therapeutics, Inc. | 6,524 | $121.7K | — | Jan 28, 2026 | Form 4 ↗ 2 days later · 34,398 shares | Form 144 ↗ |
50 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances